Bank of Montreal Portfolio holdings
Bank of Montreal (BMO), established in 1817 as Canada’s first chartered bank and headquartered in Montreal, Quebec (with key operations in Toronto), is a major North American financial institution offering personal and commercial banking, wealth management, and capital markets services. Managing hundreds of billions in assets, BMO serves over 13 million customers, with a strong U.S. presence through BMO Harris Bank, bolstered by its 1984 acquisition of Harris Bank and the 2022 purchase of Bank of the West, expanding its footprint to 32 states. Known for its longevity and stability, BMO has paid dividends since 1829, one of the longest streaks globally, and emphasizes digital innovation and sustainable finance under CEO Darryl White. With a global reach spanning North America, Europe, and Asia, BMO blends its historical roots with a modern focus on customer-centric growth.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$475M |
| 2 |
Blackstone
BX
|
+$315M |
| 3 |
AABA
Altaba Inc
AABA
|
+$298M |
| 4 |
SPDR Gold Trust
GLD
|
+$237M |
| 5 |
Eli Lilly
LLY
|
+$182M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$384M |
| 2 |
Merck
MRK
|
+$284M |
| 3 |
Enterprise Products Partners
EPD
|
+$266M |
| 4 |
CTXS
Citrix Systems Inc
CTXS
|
+$261M |
| 5 |
Royal Bank of Canada
RY
|
+$226M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 26.66% |
| 2 | Miscellaneous | 10.37% |
| 3 | Energy | 9.81% |
| 4 | Technology | 9.71% |
| 5 | Industrials | 8.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2901
Enerpac Tool Group
EPAC
$1.79B
| $128K | ﹤0.01% |
5,035
| – | – |
2013 Q2
18 quarters
|
|
2902
Globant
GLOB
$1.6B
| $128K | ﹤0.01% |
2,739
| – | – |
2016 Q2
6 quarters
|
|
2903
Saic
SAIC
$5.29B
| $128K | ﹤0.01% |
1,668
+708
| +74% | +$51.2K |
2013 Q4
16 quarters
|
|
|
FGP
2904
DELISTED
Ferrellgas Partners, L.P.
FGP
| $128K | ﹤0.01% |
30,000
-5,000
| -14% | -$23K |
2013 Q2
18 quarters
|
|
2905
Braskem
BAK
$618M
| $127K | ﹤0.01% |
4,828
-2,472
| -34% | -$70.6K |
2016 Q3
5 quarters
|
|
2906
Nordic American Tanker
NAT
$1.73B
| $127K | ﹤0.01% |
51,723
-25,799
| -33% | -$107K |
2013 Q2
18 quarters
|
|
2907
PIMCO Corporate & Income Opportunity Fund
PTY
$2.44B
| $127K | ﹤0.01% |
7,736
-965
| -11% | -$16.1K |
2014 Q1
15 quarters
|
|
|
MYOK
2908
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $127K | ﹤0.01% |
3,010
-990
| -25% | -$38.1K |
2017 Q3
1 quarter
|
|
2909
Otter Tail
OTTR
$3.71B
| $126K | ﹤0.01% |
2,830
-16
| -0.6% | -$733 |
2015 Q3
9 quarters
|
|
|
LN
2910
DELISTED
LINE Corporation
LN
| $126K | ﹤0.01% |
3,083
| – | – |
2017 Q1
3 quarters
|
|
|
AVHI
2911
DELISTED
A V Homes, Inc.
AVHI
| $126K | ﹤0.01% |
7,562
-91
| -1% | -$1.56K |
2015 Q4
8 quarters
|
|
2912
Cimpress
CMPR
$1.83B
| $125K | ﹤0.01% |
1,046
+41
| +4% | +$4.7K |
2014 Q4
12 quarters
|
|
2913
Future FinTech Group
FTFT
$27.1M
| $125K | ﹤0.01% |
+9
| New | +$56.8K |
2017 Q4
0 quarters
|
|
2914
CytomX Therapeutics
CTMX
$573M
| $124K | ﹤0.01% |
+5,830
| New | +$121K |
2017 Q4
0 quarters
|
|
2915
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
$11B
| $124K | ﹤0.01% |
4,083
| – | – |
2014 Q2
14 quarters
|
|
|
PFPT
2916
DELISTED
Proofpoint, Inc.
PFPT
| $124K | ﹤0.01% |
1,401
-19,965
| -93% | -$1.81M |
2013 Q2
18 quarters
|
|
|
NAV
2917
DELISTED
Navistar International
NAV
| $124K | ﹤0.01% |
2,907
-2,052
| -41% | -$85.4K |
2013 Q2
18 quarters
|
|
2918
M/I Homes
MHO
$3.42B
| $123K | ﹤0.01% |
3,580
-571
| -14% | -$18.6K |
2013 Q2
18 quarters
|
|
2919
Protagonist Therapeutics
PTGX
$9.01B
| $123K | ﹤0.01% |
5,930
+5,430
| +1,086% | +$96.3K |
2017 Q2
2 quarters
|
|
|
MTOR
2920
DELISTED
MERITOR, Inc.
MTOR
| $123K | ﹤0.01% |
5,272
+271
| +5% | +$6.8K |
2013 Q2
18 quarters
|
|
|
MLNT
2921
DELISTED
Melinta Therapeutics, Inc. Common Stock
MLNT
| $123K | ﹤0.01% |
+1,554
| New | +$115K |
2017 Q4
0 quarters
|
|
2922
Churchill Downs
CHDN
$5.21B
| $122K | ﹤0.01% |
3,138
-336
| -10% | -$12.2K |
2015 Q3
9 quarters
|
|
2923
FS Bancorp
FSBW
$346M
| $122K | ﹤0.01% |
+4,484
| New | +$123K |
2017 Q4
0 quarters
|
|
2924
CALL
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$15.2B
| $122K | ﹤0.01% |
+1,400
| New | +$123K |
2017 Q4
0 quarters
|
|
2925
Invesco FTSE RAFI US 1000 ETF
PRF
$9.8B
| $121K | ﹤0.01% |
5,340
-1,130
| -17% | -$24.9K |
2013 Q2
18 quarters
|
|
Similar funds
Bank of Montreal's Q4 2017 Portfolio in Review
As of Q4 2017, Bank of Montreal held 4,524 positions worth $115B, up 5.4% from $109B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Bank of Montreal's Q4 2017 filing shows 340 new, 1,586 increased, 1,488 reduced and 306 closed positions. Its largest new stake was Maxar Technologies Inc. Common Stock: 2,074,218 shares worth $133M. The largest sale was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $384M.
By sector, the portfolio is most concentrated in Financials at 27% of assets, down from 27% a quarter earlier, followed by Miscellaneous and Energy.
- Bank of Montreal's largest Q4 2017 buy was Maxar Technologies Inc. Common Stock: 2,074,218 shares worth $133M.
- Bank of Montreal added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $475M increase.
- Bank of Montreal's biggest Q4 2017 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $384M.
- Bank of Montreal fully exited CR Bard Inc. in Q4 2017, selling an estimated $120M.
- Bank of Montreal's ten largest holdings make up 20% of its $115B portfolio in Q4 2017.
- Bank of Montreal opened 340 new positions and closed 306 in Q4 2017.
- Bank of Montreal's portfolio value rose 5.4% quarter-over-quarter to $115B.
Based on Bank of Montreal's 13F filing for Q4 2017, filed 16 Jan 2018.